Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fibrocystic Breast Disease | 1 | 2023 | 102 | 0.900 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2023 | 68 | 0.890 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2022 | 45 | 0.820 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2022 | 140 | 0.770 |
Why?
|
| Breast Neoplasms | 6 | 2024 | 20823 | 0.740 |
Why?
|
| Phyllodes Tumor | 1 | 2020 | 53 | 0.730 |
Why?
|
| Carboxyhemoglobin | 1 | 2020 | 81 | 0.720 |
Why?
|
| Blood Substitutes | 1 | 2020 | 58 | 0.710 |
Why?
|
| Angiolipoma | 1 | 2019 | 13 | 0.710 |
Why?
|
| Mastectomy, Modified Radical | 1 | 2019 | 62 | 0.690 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 101 | 0.660 |
Why?
|
| Benzimidazoles | 1 | 2024 | 850 | 0.650 |
Why?
|
| Ultrasonography, Mammary | 1 | 2019 | 250 | 0.590 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2023 | 808 | 0.570 |
Why?
|
| Fluorocarbons | 1 | 2020 | 452 | 0.500 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 1182 | 0.480 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 948 | 0.480 |
Why?
|
| Hemoglobins | 1 | 2020 | 1532 | 0.470 |
Why?
|
| Blood Transfusion | 1 | 2020 | 1301 | 0.450 |
Why?
|
| Paclitaxel | 1 | 2019 | 1708 | 0.410 |
Why?
|
| Neoplasms, Second Primary | 1 | 2019 | 1062 | 0.390 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 2249 | 0.380 |
Why?
|
| Anemia | 1 | 2020 | 1503 | 0.370 |
Why?
|
| Research Design | 1 | 2024 | 5986 | 0.310 |
Why?
|
| Adenocarcinoma | 1 | 2023 | 6364 | 0.270 |
Why?
|
| Breast | 2 | 2023 | 1970 | 0.230 |
Why?
|
| GATA3 Transcription Factor | 1 | 2023 | 157 | 0.220 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 5263 | 0.210 |
Why?
|
| Ki-67 Antigen | 1 | 2024 | 644 | 0.200 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 11126 | 0.190 |
Why?
|
| Aminopyridines | 1 | 2024 | 542 | 0.180 |
Why?
|
| Muscles | 1 | 2023 | 1614 | 0.160 |
Why?
|
| Hyperplasia | 1 | 2021 | 1185 | 0.160 |
Why?
|
| Ovary | 1 | 2022 | 981 | 0.150 |
Why?
|
| Urinary Bladder | 1 | 2023 | 1173 | 0.150 |
Why?
|
| Disinfection | 1 | 2018 | 191 | 0.140 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2019 | 624 | 0.130 |
Why?
|
| Pancreas | 1 | 2020 | 1687 | 0.110 |
Why?
|
| Repressor Proteins | 1 | 2023 | 3024 | 0.110 |
Why?
|
| Mammography | 1 | 2021 | 2475 | 0.090 |
Why?
|
| Female | 6 | 2024 | 380200 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 1400 | 0.080 |
Why?
|
| Cross Infection | 1 | 2018 | 1417 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2023 | 13035 | 0.080 |
Why?
|
| Humans | 9 | 2024 | 744376 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2023 | 10484 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11366 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 11031 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2018 | 3680 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12961 | 0.060 |
Why?
|
| Inflammation | 1 | 2023 | 10636 | 0.060 |
Why?
|
| Hygiene | 1 | 2018 | 97 | 0.040 |
Why?
|
| Staphylococcus | 1 | 2018 | 155 | 0.040 |
Why?
|
| Disinfectants | 1 | 2018 | 116 | 0.040 |
Why?
|
| Male | 2 | 2023 | 350118 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 63115 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77459 | 0.030 |
Why?
|
| Aged | 1 | 2019 | 163284 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 213388 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19905 | 0.010 |
Why?
|
Concepts
(60)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_